µ¼Ê¦ÐÕÃû£ºÀî»ã»ª
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º107
ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º¹«¹²ÎÀÉúѧԺ
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ÐÄѪ¹Ü¼²²¡£¨°üÀ¨ÐÄÔàË¥½ß¡¢Ð£ËÀ¡¢¸ßѪѹ¼°ÐÄÂÉʧ³£µÈ£©·¢Éú·¢Õ¹µÄ²¡ÀíÉúÀí»úÖÆÑо¿¡£Ö÷Ҫ̽... [Õ¹¿ª]
Ñо¿ÁìÓò£º ÐÄѪ¹Ü¼²²¡£¨°üÀ¨ÐÄÔàË¥½ß¡¢Ð£ËÀ¡¢¸ßѪѹ¼°ÐÄÂÉʧ³£µÈ£©·¢Éú·¢Õ¹µÄ²¡ÀíÉúÀí»úÖÆÑо¿¡£Ö÷Ҫ̽ÌÖ·ºËص°°×ÖÊÐÞÊΡ¢ÃâÒßÑ×Ö¢¼°ÓªÑø´úлʧºâµ÷½ÚÐÄѪ¹Ü¼²²¡µÄ²¡ÀíÉúÀí»úÖÆ¡£ [ÊÕÆð]
ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºhhli1935@aliyun.com
¸öÈ˼òÊö :
Àî»ã»ª, ´óÁ¬Ò½¿Æ´óѧ¹«¹²ÎÀÉúѧԺԺ³¤£¬ÐÄѪ¹ÜÑо¿ËùËù³¤£¬½ÌÓý²¿³¤½Ñ§ÕßÌØÆ¸½ÌÊÚ£¬¡°¹ú¼Ò½Ü³öÇàÄê¿ÆÑ§»ù½ð¡±»ñµÃÕß¡£1998Äê»ñµÃÖйúкÍÒ½¿Æ´óѧ²©Ê¿Ñ§Î»£¬1998-2005Äê·Ö±ðÔÚÃÀ¹úWake Forest´óѧ²¡ÀíѧϵºÍÃÀ¹ú±±¿¨´óѧÐÄѪ¹ÜÉúÎïѧÑо¿ÖÐÐÄ×ö²©Ê¿ºóºÍÑо¿ÖúÀí£¬2005-2010ÄêÔÚ±±¾©ÐºÍҽѧԺ²¡ÀíѧϵÈνÌÊÚ£¬2010-2014ÄêÔÚÊ×¶¼Ò½¿Æ´óѧÈνÌÊÚ£¬2015-ÖÁ½ñÔÚ´óÁ¬Ò½¿Æ´óѧ¹¤×÷¡£½üЩÄêÈëÑ¡¡°¹ú¼Ò°ÙǧÍòÈ˲ʤ³Ì¡±²¢»ñµÃ¡°ÓÐÍ»³ö¹±Ï×ÖÐÇàÄêר¼Ò¡±¡¢ÖйúÇȽ紴ÐÂÈ˲ʱÏ×½±¡¢ÏíÊܹúÎñÔºÕþ¸®ÌØÊâ½òÌù¡¢ÁÉÄþÊ¡ÅʵÇѧÕßµÈÈÙÓþ³ÆºÅ¡£
¿ÆÑй¤×÷ :
ÔÚÑпÎÌ⣨Ö÷³Ö£©1.2017.01-2021.12: ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØµãÏîÄ¿: ¡°Ç÷»¯Òò×Ó/ÊÜÌåÐźÅͨ·µ÷¿ØÐÄÁ¦Ë¥½ß·¢²¡»úÖÆºÍ¸ÉÔ¤µÄÑо¿¡±£¨**£©¡£×ÊÖú½ð¶î£º254.00 ÍòÔª£¬¸ºÔðÈË2.2014.01-2018.12: ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØµãÏîÄ¿: ¡°·ºËؽ鵼µÄµ°°×Öʽµ½âÔÚÐļ¡·ÊºñÖеÄ×÷Óü°»úÖÆÑо¿¡±£¨**£©¡£×ÊÖú½ð¶î£º290.00 ÍòÔª£¬¸ºÔðÈË3.2016.01- 2019.12: ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿Ãû³Æ£º¡°È¥·ºËØ»¯Ã¸UCHL1¼¤»îµ¼ÖÂÐÄÁ¦Ë¥½ßµÄ²¡ÀíÉúÀí»úÖÆ¡± (**). 75.60ÍòÔª, ¸ºÔðÈË
Éç»á¼æÖ°£º2015Äê07Ô£ÖÁ½ñ£º´óÁ¬ÊÐ֪ʶ·Ö×ÓÁªÒê»á ¸±»á³¤2011Äê06Ô£ÖÁ½ñ£º ¹ú¼Ò»ù½ðίһ´¦£¨Ñ»·×飩¶þÉóר¼Ò2015Äê04Ô£ÖÁ½ñ£ºÖйúÒ½Ò©ÖÊÁ¿¹ÜÀíлáÁÙ´²ÊÔÑé¼°´óÊý¾ÝÖÊÁ¿¹ÜÀí·Ö»á ¸±Ö÷ÈÎίԱ2015Äê01Ô£ÖÁ½ñ£ºÖйú΢ѻ·Ñ§»áÖÜΧѪ¹Ü¼²²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»á ³£ÎñίԱ2011Äê11Ô£ÖÁ½ñ£ºÖйúÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ»áÖ¬ÖÊÓëÖ¬µ°°×öλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»á ίԱ2014Äê08Ô£ÖÁ½ñ£ºÖйú²¡ÀíÉúÀíѧ»áµÚ°Ë½ìÐÄѪ¹ÜöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»á ίԱ2014Äê08Ô£ÖÁ½ñ£º¹ú¼ÊÐÄÔàÑо¿»áÖйú·Ö»áµÚÁù½ìίԱ»á ίԱ
´ú±íSCIÂÛÎÄ£¨*ͨѶ»ò¹²Í¬Í¨Ñ¶£©1£®Lei Wang, Xue-Chen Zhao, Wei Cui, Yong-Qiang Ma, Hua-Liang Ren, Xin Zhou, Yan-Zong Yang, Yun-Long Xia*, Jie Du, Hui-Hua Li*. Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction. Circulation. **:1353¨C1368. (IF=17.047)2£®Xia Wang, Hong-Xia Wang, Yu-Lin Li, Cong-Cong Zhang, Chun-Yu Zhou, Lei Wang, Yun-Long Xia, Jie Du, Hui-Hua Li*. MicroRNA Let-7i Negatively Regulates Cardiac Inflammation and Fibrosis. Hypertension. 201566:776-785. (IF=6.48)3£®Qiu-Yue Han, Hong-Xia Wang, Xiao-Hong Liu, Cai-Xia Guo, Qi Hua, Xiao-Hong Yu, Nan Li, Yan-Zong Yang, Jie Du, Yun-Long Xia*, and Hui-Hua Li*. Circulating E3 ligases are novel and sensitive biomarkers for diagnosis of acute myocardial infarction. Clinical Science£¨Lond£©2015 Jun128(11):751-60.£¨IF=5.598£©4£®Lei Wang, Yu-Lin Li, Cong-Cong Zhang, Wei Cui, Xia Wang, Yong Xia, Jie Du*, Hui-Hua Li*. Inhibition of Toll-Like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. Cardiovascular Research. 2014 Mar101(3):383-92. (IF=5.94)5£®Wei Zhao, Yulin Li, Lili Pan, Hui-Hua Li*, Jie Du*. Atg5 deficiency-mediated mitophagy aggravates cardiac inflammation and injury in response to angiotensin. Free Radical Biology & Medicine, 2014 69: 108-115. (IF=5.736)6£®Hong-Xia Wang, Hui Yang, Qiuyue Han, Nan Li, Xue Jiang, Cui Tian, Jie Du*, Huihua Li*. NADPH oxidases mediate a cellular 'memory' of angiotensin II stress in hypertensive cardiac hypertrophy. Free Radical Biology & Medicine, 2013. pp. 897-907. (IF=5.71)7£®Zhang Y, Zeng Y, Wang M, Tian C, Ma X, Chen H, Fang Q, Jia L, Du J, and Li H*. Cardiac-specific overxpression of E3 ligase Nrdp1 increases ischemia and reperfusion-induced cardiac injury. Basic Research in Cardiology. 2011, 106(3):371-83. £¨IF=5.955£©8£®Yang D., Xie P, Guo S, Li H*. Induction of MAPK phosphatase-1 by hypothermia inhibits tumor necrosis factor-alpha-induced endothelial barrier dysfunction and apoptosis. Cardiovascular Research. 2010 Feb 185(3):520-529.£¨IF=5.808£©9£®Hui-Hua Li*, Monte S. Willis, Pamela Lockyer, Nathaniel Miller, Holly McDonough, David J. Glass and Cam Patterson*. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J. Clinical Investigation. **(11): 3211¨C3223.£¨IF=13.612£©10£®Hui-Hua Li, Vishram Kedar, Chunlian Zhang, Holly McDonough, Ranjana Arya, Da-Zhi Wang, and Cam Patterson. Atrogin-1/ muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J. Clinical Investigation. 2004£»114 1058-1071.£¨IF=13.612£©
´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àî»ã»ª
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/²¡Àí ÉúÀí ´óÁ¬Ò½¿Æ´óѧ ÐÄѪ¹Ü È˲Å
´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-À¾ü
µ¼Ê¦ÐÕÃû£ºÀ¾üÐÔ±ð£ºÈËÆøÖ¸Êý£º107ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£º»ù´¡Ò½Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÈËÀ೦µÀ¾úȺÓëÂýÐÔ´úлÐÔ¼²²¡¹ØÏµ¼°»úÖÆµÄÑо¿¡£Î¢ÉúÌ¬ÖÆ¼ÁµÄÆÀ¼ÛÓëÓ¦ÓÃÑо¿¡£Ñо¿ÁìÓò£ºÈËÀ೦µÀ¾úȺÓëÂýÐÔ´úлÐÔ¼²²¡¹ØÏµ¼°»úÖÆµÄÑо¿¡£Î¢ÉúÌ¬ÖÆ¼ÁµÄÆÀ¼ÛÓëÓ¦ÓÃÑо¿¡£[ÊÕÆð]ͨѶ·½Ê½ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁõÌìÇä
µ¼Ê¦ÐÕÃû£ºÁõÌìÇäÐÔ±ð£ºÈËÆøÖ¸Êý£º107ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º²¡ÀíÓ벡ÀíÉúÀíѧÑо¿ÁìÓò£ºÖ×Áö·¢²¡»úÖÆºÍÉúÎïѧÐÐΪ¡£Ñо¿ÁìÓò£ºÖ×Áö·¢²¡»úÖÆºÍÉúÎïѧÐÐΪ¡£[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºliutianqing1961@126.com¸öÈ˼òÊö:ÁõÌìÇ䣬´óÁ¬ÊÐÓÑÒêÒ½Ôº²¡Àí¿ÆÖ÷ÈÎ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àî¶«°×
µ¼Ê¦ÐÕÃû£ºÀî¶«°×ÐÔ±ð£ºÈËÆøÖ¸Êý£º107ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÂé×íöλÔÓéÀֵǼÈë¿ÚÏÂÔØÑо¿ÁìÓò£º1¡¢Âé×íÒ©Îï¶ÔÈÏÖª¹¦ÄܵÄÓ°Ï죬°üÀ¨»ù´¡ÁÙ´²Ñо¿2¡¢²»Í£Ìø´îÇŶԲ¡ÀíÉúÀíÓ°ÏìµÄÑо¿3¡¢À§ÄÑÆø...[Õ¹¿ª]Ñо¿ÁìÓò£º1¡¢Âé×íÒ©Îï¶ÔÈÏÖª¹¦ÄܵÄÓ°Ï죬°üÀ¨»ù´¡ÁÙ´²Ñо¿2¡¢²» ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-µËÏþÇÙ
µ¼Ê¦ÐÕÃû£ºµËÏþÇÙÐÔ±ð£ºÈËÆøÖ¸Êý£º107ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ×ÁöѧÑо¿ÁìÓò£ºÈéÏÙ°©¼°¸¹²¿Ö×ÁöµÄ·ÅÉäÖÎÁÆÓë×ÛºÏÖÎÁÆ¡£·Î°©µÄ·Å»¯Í¬²½×ÛºÏÖÎÁÆÒÔ¼°·ÅÉäÐÔ·ÎÑ׺ͷÎËðÉ˵ķÀÖΡ£Ñо¿ÁìÓò£ºÈéÏÙ°©¼°¸¹²¿Ö×ÁöµÄ·ÅÉäÖÎÁÆÓë×ÛºÏÖÎÁÆ¡£·Î°©µÄ·Å»¯Í¬²½×ÛºÏÖÎÁÆÒÔ¼°·ÅÉäÐÔ·Î ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕźêÓ±
µ¼Ê¦ÐÕÃû£ºÕźêÓ±ÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º106ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£º»ù´¡Ò½Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ×Áöϸ°ûϵ½¨Á¢£¬Ö×Áöϸ°ûĤÁ×Ö¬ÓëÖ×Áö×ªÒÆµÄ¹ØÏµ£¬Ö×ÁöÒ©ÎïÖÎÁÆ»úÖÆÑо¿ÁìÓò£ºÖ×Áöϸ°ûϵ½¨Á¢£¬Ö×Áöϸ°ûĤÁ×Ö¬ÓëÖ×Áö×ªÒÆµÄ¹ØÏµ£¬Ö×ÁöÒ©ÎïÖÎÁÆ»úÖÆ[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¸ßÓñÑ©
µ¼Ê¦ÐÕÃû£º¸ßÓñÑ©ÐÔ±ð£ºÈËÆøÖ¸Êý£º106ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÆ¤·ôÐÔ²¡Ñ§Ñо¿ÁìÓò£ºÆ¤·ô¼¤¹âÃÀÈÝËðÈÝÐÔÆ¤·ô²¡Ñо¿ÁìÓò£ºÆ¤·ô¼¤¹âÃÀÈÝËðÈÝÐÔÆ¤·ô²¡[ÊÕÆð]¸öÈ˼òÊö:¸ßÓñÑ©£¬½ÌÊÚ£¬Ö÷ÈÎҽʦ£¬Ò½Ñ§Ë¶Ê¿£¬Ë¶Ê¿Éúµ¼Ê¦¡£1989Äê±ÏÒµÓÚ°×Çó¶÷Ò½¿Æ´óѧҽѧϵ£¬´ÓÊ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Ñî½øÒæ
µ¼Ê¦ÐÕÃû£ºÑî½øÒæÐÔ±ð£ºÈËÆøÖ¸Êý£º107ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÃÚÄòÍâ¿ÆÑо¿ÁìÓò£º1¡¢ÏÂÄò·¹£×è¡¢ÅÅÄò¹¦ÄÜÕϰµÄ»úÀí¡¢°òë×±ÆÄò¼¡ÐÎ̬¼°¹¦ÄܵÄÑо¿¡£2¡¢°òë×°©·¢²¡»úÀíµÄ·Ö×ÓÉú...[Õ¹¿ª]Ñо¿ÁìÓò£º1¡¢ÏÂÄò·¹£×è¡¢ÅÅÄò¹¦ÄÜÕϰµÄ»úÀí¡¢°òë×±ÆÄò¼¡ÐÎ̬¼°¹¦ÄܵÄÑо¿¡£2¡¢°òë× ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÍôÄÏÆ½
µ¼Ê¦ÐÕÃû£ºÍôÄÏÆ½ÐÔ±ð£ºÈËÆøÖ¸Êý£º105ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÒ½Ñ§¿ÆÑ§Ñо¿ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£º²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1£®ÐÄѪ¹Ü²¡£º¶¯ÂöÖàÑùÓ²»¯¼°Ñª¹ÜÔÙÏÁÕ·Ö×Ó²¡Àí»úÖÆÑо¿£»2£®ÌÇÄò²¡·ÀÖΣºÌÇÄò²¡Ñª¹Ü²¡±äµÄ·Ö...[Õ¹¿ª]Ñо¿ÁìÓò£º1£®ÐÄѪ¹Ü²¡£º¶¯ÂöÖàÑùÓ²»¯¼°Ñª¹ÜÔÙÏÁÕ·Ö×Ó²¡Àí»úÖÆÑо¿£»2 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÅÕÜ
µ¼Ê¦ÐÕÃû£ºÕÅÕÜÐÔ±ð£ºÈËÆøÖ¸Êý£º105ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÍâ¿ÆÑ§Ñо¿ÁìÓò£º·Î°©µÄÁÙ´²×ÛºÏÕïÁÆÒÔ¼°Î¸Ê³¹Ü·´Á÷²¡µÄÍâ¿ÆÖÎÁÆÑо¿ÁìÓò£º·Î°©µÄÁÙ´²×ÛºÏÕïÁÆÒÔ¼°Î¸Ê³¹Ü·´Á÷²¡µÄÍâ¿ÆÖÎÁÆ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºdoctorzhangzhe@aliyun.com¸öÈ˼ò ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÌÆÀÖ÷
µ¼Ê¦ÐÕÃû£ºÌÆÀÖ÷ÐÔ±ð£ºÈËÆøÖ¸Êý£º105ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÓ°ÏñҽѧÓëºËҽѧÑо¿ÁìÓò£ºÉñ¾ÏµÍ³Ö×Áö¡¢ÍÑËèÇÊÐÔ²¡±ä¼°±äÐÔÐÔ¼²²¡µÄÓ°ÏñÑо¿¡£Ñо¿ÁìÓò£ºÉñ¾ÏµÍ³Ö×Áö¡¢ÍÑËèÇÊÐÔ²¡±ä¼°±äÐÔÐÔ¼²²¡µÄÓ°ÏñÑо¿¡£[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºLemeitang@12 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-»Æº£ÌÎ
µ¼Ê¦ÐÕÃû£º»Æº£ÌÎÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º105ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¿ÚÇ»ò¢ÃæÍâ¿ÆÍ¨Ñ¶·½Ê½:µç×ÓÓʼþ£ºhht945@hotmail.com¸öÈ˼òÊö:»Æº£ÌΣ¬ÄУ¬²©Ê¿£¬¸±Ö÷ÈÎҽʦ£¬¿ÚÇ»¿Æ¸±Ö÷ÈΣ¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£Öлª¿Úǻҽѧ»á¿ÚÇ»ò¢ÃæÍâ¿ÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»áÇàÄêίԱ£¬ÖÐ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-½ùæÂ
µ¼Ê¦ÐÕÃû£º½ùæÂÐÔ±ð£ºÈËÆøÖ¸Êý£º105ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºÂí¿Ë˼Ö÷ÒåѧԺְ³Æ£ºµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºË¼ÏëÕþÖνÌÓýͨѶ·½Ê½:µç×ÓÓʼþ£ºdyjinyuan@126.com¸öÈ˼òÊö:½üÄêÀ´ËýÏȺóÖ÷³Ö²¢Íê³ÉÁËÁÉÄþÊ¡Éç»á¿ÆÑ§¹æ»®»ù½ð¿ÎÌâ¡¢ÁÉÄþÊ¡½ÌÓýÌü¿ÎÌâ¡¢´óÁ¬ÊÐÉç¿ÆÁª¿ÎÌâµÈ13Ïî¡¢ÁÉÄþÊ¡¸ßУµ³½¨¿ÎÌâ5 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Îļӱó
µ¼Ê¦ÐÕÃû£ºÎļӱóÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º104ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿ÆÑ§Ñо¿ÁìÓò£º·Î½á½ÚºÍ·Î°©»ù´¡ÓëÁÙ´²Ñо¿£»µç×ÓÌýÕïÆ÷ÁÙ´²¼¼ÄÜÅàѵ½ÌѧӦÓÃÑо¿£»·Î¶¯Âö¸ßѹÎÞ´´¼ì²â¼°ÉúÎïÐÅ...[Õ¹¿ª]Ñо¿ÁìÓò£º·Î½á½ÚºÍ·Î°©»ù´¡ÓëÁÙ´²Ñо¿£»µç×ÓÌýÕïÆ÷ÁÙ´²¼¼ÄÜÅàѵ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÒóÑã
µ¼Ê¦ÐÕÃû£ºÒóÑãÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º104ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉñ¾²¡Ñ§Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚ×ÔÊÉÔÚÉñ¾ÏµÍ³¼²²¡µÄ×÷ÓûúÖÆ£¬ÅÁ½ðɲ¡µÄ»ù´¡ºÍÁÙ´²Ñо¿¼°ÄÔѪ¹Ü²¡µÄ¸Éϸ°ûÖÎÁÆ¡£ÑÐ...[Õ¹¿ª]Ñо¿ÁìÓò£ºÖ÷ÒªÖÂÁ¦ÓÚ×ÔÊÉÔÚÉñ¾ÏµÍ³¼²²¡µÄ×÷ÓûúÖÆ£¬ÅÁ½ðɲ¡µÄ»ù´¡ºÍ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÅÑå
µ¼Ê¦ÐÕÃû£ºÕÅÑåÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º104ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿ÆÑ§·çʪ²¡Ñ§¡¢ÖÐÎ÷Ò½½áºÏÄÚ¿ÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØÑо¿ÁìÓò£ºÀà·çʪ¹Ø½ÚÑ×·¢²¡»úÖÆ¼°ÖÐÎ÷Ò½½áºÏÖÎÁÆ¡£Ñо¿ÁìÓò£ºÀà·çʪ¹Ø½ÚÑ×·¢²¡»úÖÆ¼°ÖÐÎ÷Ò½½áºÏÖÎÁÆ¡£[ÊÕÆð]¸öÈ˼òÊö:ÕÅÑ壬Ů£¬1971Äê³öÉú£¬·çʪÃâÒ߿Ƹ±Ö÷ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
